NDASUBLINGUALTABLET
Approved
Jun 2018
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
2
Clinical Trials (2)
NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden
Started Jul 2021
1,099,551 enrolled
Adverse Drug Event
Desmopressin Acetate 0.2 mg Tablets, Fasting
Started Jul 2003
48 enrolled
Healthy
Loss of Exclusivity
LOE Date
Apr 13, 2030
50 months away
Patent Expiry
Apr 13, 2030